Semaglutide UK: Access, Eligibility, Safety and Options in 2026
Semaglutide has gained popularity among the most talked-about drugs in the United Kingdom for type 2 diabetes and obesity treatment. Sold under the names Ozempic and Rybelsus for diabetes and Wegovy for obesity and other uses, this drug remains a significant influence in clinical practice and treatment choice among NHS and private patients in 2026.
The following guide provides useful...